Revvity, Inc.

US$155.11As of Sun 8 Nov 2026, 12:00 UTC
NYSE:RVTYHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 12.08%
Div yield 0.18%
ROE 3.45%
Diagnostics & Research
Beta (5Y) 1.09
PE TTM 68.65
TSR TTM 66.14%
Mkt cap US$17.31B
ROIC 4.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$167
7.48%
(63.81%)
Buy 6|9|1|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.06
2.15
2.30
2.40
12.63%
5.92%
15.00%
25.09%
Revenue$M
903.7
922.8
913.0
945.4
4.42%
5.05%
6.31%
6.60%
Peers (US$17.31B)
Cap (US$)
PE
18.27B
36.22x
17.00B
34.65x
Capital
TTM
5Y
10Y
Leveragex
0.224
0.463
0.434
EBIT/Intx
18.58
0.666
0.553
Own earn%
38.39
(18.32)
(5.02)
Sh yield%
30.51
14.47
15.02
Owners
Insiders/Inst%
8.36
81.14
Short interest%
1.87
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
8–15
$1 testx
0.0
Incr. ROIC%
0